Sanofi refines expectations on drop in sales at diabetes arm supriya kashyap kashyap6 Nov 2017 9:45 AM ISTParis: Sanofi confirmed its 2017 outlook after it posted slightly lower-than-expected third-quarter results, and gave a more precise range on...
Pfizer expects broad interest for consumer health business supriya kashyap kashyap6 Nov 2017 9:30 AM ISTNew York: Pfizer Inc, the largest U.S. drugmaker, expects no shortage of suitors for its consumer health business and said it would decide whether to...
US states allege broad generic drug price-fixing collusion supriya kashyap kashyap5 Nov 2017 1:06 PM ISTWashington: A large group of US states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving to widen an earlier...
AstraZeneca asthma drug tralokinumab disappoints again supriya kashyap kashyap5 Nov 2017 9:50 AM ISTLondon: An experimental biotech drug for severe asthma from AstraZeneca has failed in further clinical tests, following an earlier setback in May and...
GSK gets boost for early cancer hopes with breakthrough status supriya kashyap kashyap5 Nov 2017 9:15 AM ISTLondon: GlaxoSmithKline received a boost for its oncology research on Thursday when an experimental drug for blood cancer received a "breakthrough"...
Natco Pharma Q2 net up 27 pc at Rs 84 crores supriya kashyap kashyap4 Nov 2017 2:30 PM ISTNew Delhi: Natco Pharma today reported a 27.49 percent rise in consolidated net profit to Rs 84.4 crore for the second quarter ended September 30,...
AstraZeneca licenses genetic disease drug to Mereo BioPharma supriya kashyap kashyap4 Nov 2017 10:06 AM ISTLondon: Mereo BioPharma has agreed a licensing deal and acquisition option for a rare disease drug from AstraZeneca as the big drugmaker continues to...
Teva shares topple on profit warning, uncertain future supriya kashyap kashyap4 Nov 2017 9:47 AM ISTJERUSALEM: Teva Pharmaceutical Industries (TEVA.TA), the world’s biggest generic medicine maker, came under investor and market pressure after saying...
GSK and Gilead go head to head as HIV drugs enter new phase supriya kashyap kashyap4 Nov 2017 9:47 AM ISTLondon: Gilead Sciences (GILD.O) and GlaxoSmithKline (GSK.L) are heading for an HIV showdown, pushing rival treatment visions and competing products...
Novartis to buy French cancer specialist AAA for $3.9 billion supriya kashyap kashyap3 Nov 2017 1:21 PM ISTZurich: Novartis has agreed to buy French-based Advanced Accelerator Applications (AAA) for $3.9 billion, giving it a platform in radiopharmaceuticals...
German drug regulator finds dirty rooms in Dr Reddy's facility supriya kashyap kashyap3 Nov 2017 1:07 PM ISTA German government's drug regulating agency, which audited one of Dr Reddy's Laboratories manufacturing facilities here, found "dirty rooms and...
Zydus Nesher Pharma gets USFDA nod for ADHD tablets supriya kashyap kashyap3 Nov 2017 1:00 PM ISTNew Delhi: Zydus Group firm Cadila Healthcare said Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA, has received final approval from...
